Knockdown of NOB1 expression by RNAi inhibits cellular proliferation and migration in human gliomas
- PMID: 23911301
- DOI: 10.1016/j.gene.2013.07.032
Knockdown of NOB1 expression by RNAi inhibits cellular proliferation and migration in human gliomas
Abstract
NOB1 (NIN1/RPN12 binding protein 1 homolog), a ribosome assembly factor, is thought to be essential for the processing of the 20S pre-rRNA into the mature 18S rRNA. It is also reported to participate in proteasome biogenesis. However, the contribution of NOB1 gene dysfunction to the pathology of human diseases, such as gliomas, has not been addressed. Here, we detected expression levels of NOB1 mRNA in U251, U87, U373, and A172 cells by quantitative real-time PCR. To analyze the expression levels of NOB1 protein in glioma tissues, we performed immunohistochemistry on 56 pathologically confirmed glioma samples (7 Grade I cases, 19 Grade II cases, 16 Grade III cases, and 14 Grade IV cases). A recombinant lentivirus expressing NOB1 short hairpin RNA (shNOB1) was constructed and infected into U251 and U87-MG human glioma cells. We found that NOB1 mRNA was expressed in all four cell lines. The expression level of the NOB1 protein was significantly higher in high-grade gliomas than in low-grade gliomas. Knockdown of the NOB1 gene resulted in suppression of the proliferation and the colony-forming abilities of U251 and U87-MG cells, cell cycle arrest during the G0/G1 phase, and a significant enhancement of cell apoptosis. In addition, cell migration was significantly suppressed in U251 and U87-MG cells that were infected with the shNOB1-expressing lentivirus. These results suggest that NOB1 promotes glioma cell growth and migration and could be a candidate for molecular targeting during gene therapy treatments of glioma.
Keywords: 26S proteasome non-ATPase regulatory subunit 8 binding protein 1; 3,3′-diaminobenzidine; ATCC; American Type Culture Collection; BCA; BSA; Bicinchoninic acid; Bovine serum albumin; DAB; DMEM; Dulbecco's modified Eagle's medium; FACS; FBS; Fetal bovine serum; Fluorescence-activated cell sorting; GAPDH; GFP; Glioma; Glyceraldehyde3-phosphate dehydrogenase; Green Fluorescent Protein; HEK; Homologues of the pilT N-terminal domain; Human embryonic kidney; IHC; Immunohistochemistry; M-MLV Reverse Transcriptase; M-MLV-RT; MOI; MTT; Methylthiazoletetrazolium; Migration; Multiplicity of infection; NIN1/RPN12 binding protein 1 homolog; NOB1; PI; PIN domain; PSMD8BP1; Proliferation; Propidium iodide; RNA interference; RNAi; Short-hairpin RNA; Small interfering RNA; TRITC; Tetraethyl rhodamine isothiocyanate; WHO; World Health Organization; shRNA; siRNA.
© 2013.
Comment in
-
Identity confusion of glioma cell lines.Gene. 2014 Feb 15;536(1):221-2. doi: 10.1016/j.gene.2013.11.096. Epub 2013 Dec 12. Gene. 2014. PMID: 24333272 No abstract available.
Similar articles
-
Evaluation of NIN/RPN12 binding protein inhibits proliferation and growth in human renal cancer cells.Tumour Biol. 2015 Mar;36(3):1803-10. doi: 10.1007/s13277-014-2783-2. Epub 2014 Nov 26. Tumour Biol. 2015. PMID: 25420906
-
[Effect of lentivirus-mediated NOB1 gene silencing by RNA interference on proliferation and apoptosis of human colon cancer cells].Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Nov;15(11):1182-6. Zhonghua Wei Chang Wai Ke Za Zhi. 2012. PMID: 23172535 Chinese.
-
Downregulation of NOB1 inhibits proliferation and promotes apoptosis in human oral squamous cell carcinoma.Oncol Rep. 2015 Dec;34(6):3077-87. doi: 10.3892/or.2015.4271. Epub 2015 Sep 11. Oncol Rep. 2015. PMID: 26370469
-
NOB1: A Potential Biomarker or Target in Cancer.Curr Drug Targets. 2019;20(10):1081-1089. doi: 10.2174/1389450120666190308145346. Curr Drug Targets. 2019. PMID: 30854959 Review.
-
Ribosome Biogenesis and Cancer: Insights into NOB1 and PNO1 Mechanisms.Curr Pharm Des. 2024;30(37):2911-2921. doi: 10.2174/0113816128301870240730071910. Curr Pharm Des. 2024. PMID: 39143880 Review.
Cited by
-
Prognostic value of NOB1 expression levels in various cancers: a systematic review and meta-analysis.Biomark Med. 2024;18(13-14):619-628. doi: 10.1080/17520363.2024.2352408. Epub 2024 Jun 17. Biomark Med. 2024. PMID: 38881528 Free PMC article.
-
Regulation of Molecular Targets in Osteosarcoma Treatment.Int J Mol Sci. 2022 Oct 20;23(20):12583. doi: 10.3390/ijms232012583. Int J Mol Sci. 2022. PMID: 36293439 Free PMC article. Review.
-
Anticancer activity of NOB1-targeted shRNA combination with TRAIL in epithelial ovarian cancer cells.Int J Clin Exp Pathol. 2015 Sep 1;8(9):10061-71. eCollection 2015. Int J Clin Exp Pathol. 2015. Retraction in: Int J Clin Exp Pathol. 2021 Jul 15;14(7):856. PMID: 26617713 Free PMC article. Retracted.
-
microRNA-744 is downregulated in glioblastoma and inhibits the aggressive behaviors by directly targeting NOB1.Am J Cancer Res. 2018 Nov 1;8(11):2238-2253. eCollection 2018. Am J Cancer Res. 2018. PMID: 30555741 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous